For research use only
| Cat No. | ABC-TC3508 |
| Product Type | Nervous Cells |
| Cell Type | Astrocyte |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Astrocytes-Spinal Cord from AcceGen Research Laboratories are isolated from human spinal cord.
Human Astrocytes-Spinal Cord are primary cells isolated from human spinal cord tissue and cryopreserved at low passage to maintain their native biological properties. These specialized glial cells exhibit a typical stellate morphology and adherent growth pattern. Functionally, they contribute to astrocyte blood-brain barrier function, mediate spinal cord astrocyte development, support neuronal survival, and regulate extracellular ion balance. Their malfunction is linked to spinal cord-related disorders, such as injury-induced neurodegeneration. Strong expression of glial fibrillary acidic protein (GFAP) is confirmed, validating their astrocytic identity. Repeated freezing and thawing should be avoided during culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Spinal Cord Astrocytes, Astrocytes Spinal Cord Human, Human Spinal Glial Cells, Spinal Astroglia Human, HAST-SpinalCord |
| Species | Human |
| Cat.No | ABC-TC3508 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Astrocyte |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Nervous Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Astrocytes-Spinal Cord can be used as an in vitro cell model to study the pathogenesis of spinal cord-related disorders such as spinal cord injury and neurodegenerative diseases affecting the spinal cord. Their region-specific characteristics enable investigation of critical pathological and repair mechanisms, including neurotrophic factor secretion patterns, inflammatory mediator release, and glial scar formation processes. Researchers can utilize this system to get a better understanding of the spinal cord’s physiological repair mechanisms and pathological alterations. This knowledge is beneficial for exploring potential treatments, such as developing strategies to enhance astrocyte-mediated neuroprotection and promote functional recovery after spinal cord injury.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).